Related references
Note: Only part of the references are listed.Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteins
Hae-Ji Kang et al.
PARASITE IMMUNOLOGY (2021)
Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants
Idessania Nazareth Costa et al.
FRONTIERS IN MICROBIOLOGY (2021)
A Carbamoyl Phosphate Synthetase II (CPSII) Deletion Mutant of Toxoplasma gondii Induces Partial Protective Immunity in Mice
Xunhui Zhuo et al.
FRONTIERS IN MICROBIOLOGY (2021)
Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice
Abdol Sattar Pagheh et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)
Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection
Nadia Arcon et al.
VACCINE (2021)
Radiation effects on Toxoplasma antigens: different immune responses of irradiated intact tachyzoites or soluble antigens in experimental mice models
Andrea da Costa et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2020)
Toxoplasma gondii tkl1 Deletion Mutant Is a Promising Vaccine against Acute, Chronic, and Congenital Toxoplasmosis in Mice
Jin-Lei Wang et al.
JOURNAL OF IMMUNOLOGY (2020)
Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection
Mio Maeta et al.
MOLECULAR PHARMACEUTICS (2020)
Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host
Delphine Le Roux et al.
VACCINE (2020)
Toxoplasma gondiiADSL Knockout Provides Excellent Immune Protection against a Variety of Strains
Luyao Wang et al.
VACCINES (2020)
RHΔgra17Δnpt1 Strain of Toxoplasma gondii Elicits Protective Immunity Against Acute, Chronic and Congenital Toxoplasmosis in Mice
Qin-Li Liang et al.
MICROORGANISMS (2020)
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Ming Te Yeh et al.
CELL HOST & MICROBE (2020)
Immunostimulatory efficacy and protective potential of putative TgERK7 protein in mice experimentally infected by Toxoplasma gondii
Zhong-Yuan Li et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice
Min-Ju Kim et al.
MICROBIAL PATHOGENESIS (2020)
Identification of Toxoplasma Gondii Tyrosine Hydroxylase (TH) Activity and Molecular Immunoprotection against Toxoplasmosis
Zhenchao Zhang et al.
VACCINES (2020)
Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infection
Hae-Ji Kang et al.
PARASITE IMMUNOLOGY (2020)
Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection
Hui Sun et al.
MICROBIAL PATHOGENESIS (2020)
Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB/c mice
Masoud Foroutan et al.
MICROBIAL PATHOGENESIS (2020)
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
Kamal El Bissati et al.
SCIENTIFIC REPORTS (2020)
Effective Nanoparticle-Based Nasal Vaccine Against Latent and Congenital Toxoplasmosis in Sheep
Celine Ducournau et al.
FRONTIERS IN IMMUNOLOGY (2020)
Toxoplasma gondii alpha-amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis
Jing Yang et al.
MICROBIAL BIOTECHNOLOGY (2020)
Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations
Hae-Ji Kang et al.
PHARMACEUTICS (2020)
The Immunogenic and Immunoprotective Activities of Recombinant Chimeric T. gondii Proteins Containing AMA1 Antigen Fragments
Justyna Gatkowska et al.
VACCINES (2020)
Modulation Effects of Toxoplasma gondii Histone H2A1 on Murine Macrophages and Encapsulation with Polymer as a Vaccine Candidate
Zhengqing Yu et al.
VACCINES (2020)
Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice
Yu-Chao Zhu et al.
PARASITE (2020)
Nanoparticle formulated vaccines: opportunities and challenges
Pingsai Lung et al.
NANOSCALE (2020)
Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide
Edwin F. Sanchez-Lopez et al.
PARASITES & VECTORS (2019)
Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives
Jin-Lei Wang et al.
TRENDS IN PARASITOLOGY (2019)
An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats
Chandra Ramakrishnan et al.
SCIENTIFIC REPORTS (2019)
The Virulence-Related MYR1 Protein of Toxoplasma gondii as a Novel DNA Vaccine Against Toxoplasmosis in Mice
Bin Zheng et al.
FRONTIERS IN MICROBIOLOGY (2019)
Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor
Kang Liu et al.
FRONTIERS IN MICROBIOLOGY (2019)
Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection
Hae-Ji Kang et al.
PHARMACEUTICS (2019)
Evaluation of protective immunity induced by recombinant calcium-dependent protein kinase 1 (TgCDPK1) protein against acute toxoplasmosis in mice
Si-Yang Huang et al.
MICROBIAL PATHOGENESIS (2019)
Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice
Abdol Sattar Pagheh et al.
MICROBIAL PATHOGENESIS (2019)
Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses
Su-Hwa Lee et al.
PLOS ONE (2019)
Immunization With a Live-Attenuated RH:ΔNPT1 Strain of Toxoplasma gondii Induces Strong Protective Immunity Against Toxoplasmosis in Mice
Wen-Bin Yang et al.
FRONTIERS IN MICROBIOLOGY (2019)
QuilA-Adjuvanted T. gondii Lysate Antigens Trigger Robust Antibody and IFNγ+ T Cell Responses in Pigs Leading to Reduction in Parasite DNA in Tissues Upon Challenge Infection
Mizanur Rahman et al.
FRONTIERS IN IMMUNOLOGY (2019)
Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice
Sara Ayazian Mavi et al.
INFECTION AND DRUG RESISTANCE (2019)
Vaccination with recombinant Toxoplasma gondii CDPK3 induces protective immunity against experimental toxoplasmosis
Minmin Wu et al.
ACTA TROPICA (2019)
IL-17 and IL-22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice
Paria Alizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice
Dongchao Zhang et al.
VACCINE (2019)
Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Toxoplasma gondii Into Influenza Virus-Like Particles
Su-Hwa Lee et al.
FRONTIERS IN IMMUNOLOGY (2019)
Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6
Xiao-Pei Xu et al.
PARASITE (2019)
A one health approach to vaccines against Toxoplasma gondii
Elisabeth A. Innes et al.
FOOD AND WATERBORNE PARASITOLOGY (2019)
Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
Jingjing Guo et al.
FRONTIERS IN IMMUNOLOGY (2019)
GRA24-Based DNA Vaccine Prolongs Survival in Mice Challenged With a Virulent Toxoplasma gondii Strain
Bin Zheng et al.
FRONTIERS IN IMMUNOLOGY (2019)
Moving towards improved vaccines for Toxoplasma gondii
Yawen Li et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Gamma irradiation of Toxoplasma gondii protein extract improve immune response and protection in mice models
Andrea da Costa et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain
Aref Teimouri et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Live Attenuated Pru:Δcdpk2 Strain of Toxoplasma gondii Protects Against Acute, Chronic, and Congenital Toxoplasmosis
Jin-Lei Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites
Manlio Di Cristina et al.
PARASITOLOGY (2018)
Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16
Long-jiang Wang et al.
VACCINE (2018)
Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis
Jingjing Guo et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis
Zhenchao Zhang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis
Zineb Lakhrif et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis
Nian-Zhang Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Ildiko Rita Dunay et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice
Gang Lu et al.
PARASITE IMMUNOLOGY (2018)
Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection
Mona Roozbehani et al.
VACCINE (2018)
Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection
Su-Hwa Lee et al.
VACCINE (2018)
Metal nanoparticles restrict the growth of protozoan parasites
Oluyomi Stephen Adeyemi et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
A Lactate Fermentation Mutant of Toxoplasma Stimulates Protective Immunity Against Acute and Chronic Toxoplasmosis
Ningbo Xia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Drug Resistance in Toxoplasma gondii
Mahbobeh Montazeri et al.
FRONTIERS IN MICROBIOLOGY (2018)
Protective Efficacy Against Acute and Chronic Toxoplasma gondii Infection Induced by Immunization With the DNA Vaccine TgDOC2C
Nian-Zhang Zhang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
Zhong-Yuan Li et al.
PARASITE (2018)
Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route
Imran Rashid et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2017)
Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice
Celine Ducournau et al.
FUTURE MICROBIOLOGY (2017)
Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant
Ehsan Ahmadpour et al.
IMMUNOLOGY LETTERS (2017)
Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential
Oluyomi Stephen Adeyemi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii
E. Ahmadpour et al.
PARASITE IMMUNOLOGY (2017)
Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection
Su-Hwa Lee et al.
PLOS ONE (2017)
Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice
Ragab M. Fereig et al.
PLOS ONE (2017)
Major Immunodominant Region of Hepatitis B Virus Core Antigen as a Delivery Vector to Improve the Immunogenicity of the Fusion Antigen ROP2-SAG1 Multiepitope from Toxoplasma gondii in Mice
Wenhuan Wang et al.
VIRAL IMMUNOLOGY (2017)
Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16
Ling-Ying Hu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression
Paulo Czarnewski et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
SAG4 DNA and Peptide Vaccination Provides Partial Protection against T-gondii Infection in BALB/c Mice
Jian Zhou et al.
FRONTIERS IN MICROBIOLOGY (2017)
Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP)
Fangjun Luo et al.
FRONTIERS IN MICROBIOLOGY (2017)
Immuno-Efficacy of a T. gondii Secreted Protein with an Altered Thrombospondin Repeat (TgSPATR) As a Novel DNA Vaccine Candidate against Acute Toxoplasmosis in BALB/c Mice
Bin Zheng et al.
FRONTIERS IN MICROBIOLOGY (2017)
Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice
Jin-Lei Wang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Protein nanovaccine confers robust immunity against Toxoplasma
Kamal El Bissati et al.
NPJ VACCINES (2017)
Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2)
Kai Chen et al.
PARASITE (2017)
Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice
Wen-Bin Yang et al.
ACTA TROPICA (2017)
Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 against Acute Toxoplasmosis in BALB/c Mice
Xiao Teng Ching et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice
Guanghui Zhao et al.
ACTA TROPICA (2017)
Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticles
Shu-Chun Chuang et al.
PARASITE (2017)
Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes
Ting Wang et al.
PARASITE (2017)
DNA Vaccines: Regulatory Considerations and Safety Aspects
Anne Ingeborg Myhr
CURRENT ISSUES IN MOLECULAR BIOLOGY (2017)
Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii
Lina Zheng et al.
ACTA TROPICA (2017)
Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challenge
Dong-Hun Lee et al.
ACTA TROPICA (2016)
Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice
Zhuanzhuan Liu et al.
BMC IMMUNOLOGY (2016)
Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice
Xiu-zhen Li et al.
INFECTION GENETICS AND EVOLUTION (2016)
Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii
Dong Hun Lee et al.
PLOS ONE (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase
Zhuanzhuan Liu et al.
VACCINE (2016)
Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis
Luciana M. Bastos et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice
Xiao T. Ching et al.
FRONTIERS IN MICROBIOLOGY (2016)
Induction of Protective Immunity against Toxoplasmosis in BALB/c Mice Vaccinated with Toxoplasma gondii Rhoptry-1
Parthasarathy Sonaimuthu et al.
FRONTIERS IN MICROBIOLOGY (2016)
Recent Advances in Subunit Vaccine Carriers
Abhishek Vartak et al.
VACCINES (2016)
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii
Kamal El Bissati et al.
JCI INSIGHT (2016)
Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection
Isabelle Dimier-Poisson et al.
BIOMATERIALS (2015)
Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
Christopher Ladd Effio et al.
BIOTECHNOLOGY JOURNAL (2015)
Investigation of the protective properties of glycosylphosphatidylinositol-based vaccine candidates in a Toxoplasma gondii mouse challenge model
Sebastian Goetze et al.
GLYCOBIOLOGY (2015)
Nonreplicating, Cyst-Defective Type II Toxoplasma gondii Vaccine Strains Stimulate Protective Immunity against Acute and Chronic Infection
Barbara A. Fox et al.
INFECTION AND IMMUNITY (2015)
AMA1-Deficient Toxoplasma gondii Parasites Transiently Colonize Mice and Trigger an Innate Immune Response That Leads to Long-Lasting Protective Immunity
Vanessa Lagal et al.
INFECTION AND IMMUNITY (2015)
Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
Christopher Ladd Effio et al.
BIOTECHNOLOGY JOURNAL (2015)
Get Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal
Joel Gallant
Open Forum Infectious Diseases (2015)
The future of human DNA vaccines
Lei Li et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins
Yusuke Maeda et al.
PROGRESS IN LIPID RESEARCH (2011)
Carbohydrate vaccines: developing sweet solutions to sticky situations?
Rena D. Astronomo et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Congenital Toxoplasmosis and Reinfection during Pregnancy: Case Report, Strain Characterization, Experimental Model of Reinfection, and Review
Annie Elbez-Rubinstein et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Toxoplasmosis in sheep-The last 20 years
J. P. Dubey
VETERINARY PARASITOLOGY (2009)
Share Paper
